Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Formoterol (6mcg) + Budesonide (400mcg) Inhaler
Therapeutic Category
Asthma, Pulmonary, Respiratory
Dosage Form
Inhaler
Packaging Type
Carton and Leaflet
Packaging
120 Metered Dose
Price
₹478/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Buditerm F 400 Inhaler combines two active ingredients: formoterol and budesonide, delivering a potent formulation for the management of asthma and chronic obstructive pulmonary disease (COPD). Formoterol is a long-acting beta-agonist (LABA) that helps relax the muscles in the airways, making it easier to breathe. Budesonide, a corticosteroid, reduces inflammation in the airways, alleviating symptoms such as wheezing, coughing, and shortness of breath.
This inhaler is specifically designed for patients who require both bronchodilation and anti-inflammatory treatment to effectively control their respiratory condition. It is essential for individuals experiencing frequent symptoms or those whose asthma or COPD is not adequately managed with a single therapy. By using Buditerm F 400, patients may achieve improved lung function and enhanced quality of life.
Potential side effects include headache, throat irritation, increased heart rate, and tremors. Consult a healthcare professional for a complete list of possible reactions.
For the treatment of asthma and COPD; to relieve symptoms and improve lung function.
Use this inhaler only as prescribed. Regular monitoring by a healthcare provider is recommended to adjust treatment as needed. Buditerm F 400 Inhaler is an effective and well-tolerated option for those needing dual-action treatment for their respiratory conditions. Proper use and adherence to prescribed dosages can lead to significant improvements in symptom control and overall respiratory health. Always consult a healthcare professional before starting any new medication and report any unusual side effects promptly.
Store in a cool, dry place away from direct sunlight. Ensure the inhaler is kept out of reach of children.
Composition : Formoterol (6mcg) + Budesonide (200mcg) Inhaler
Composition : Formoterol (6mcg) + Fluticasone Propionate (250mcg)
Composition : Levosalbutamol (100mcg) + Ipratropium (80mcg)
Composition : Levosalbutamol (50mcg) + Ipratropium (20mcg)
Composition : Tiotropium (9mcg)
Composition : Formoterol (12mcg) + Tiotropium (18mcg)
Composition : Salmeterol (50mcg) + Fluticasone Propionate (500 mcg)
Composition : Doxofylline (400mg) + Montelukast (10mg)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Formoterol 6mcg + Budesonide 400mcg Inhaler has strong demand in the respiratory, pulmonology, and chronic disease management segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on asthma and COPD care portfolios.
Medical distributors and agencies can benefit from consistent demand for long-term respiratory disease management under medical supervision. Formoterol 6mcg is a long-acting beta-2 agonist (LABA) that helps relax airway muscles and improve airflow Budesonide 400mcg is an inhaled corticosteroid that helps reduce airway inflammation and prevent respiratory symptoms Commonly prescribed for bronchial asthma, chronic obstructive pulmonary disease (COPD), recurrent wheezing, and chronic inflammatory airway diseases Provides dual-action therapy through bronchodilation and inflammation control for enhanced respiratory management Widely prescribed by pulmonologists, chest physicians, and general practitioners This strengthens a comprehensive respiratory and chronic care portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Formoterol 6mcg + Budesonide 400mcg Inhaler with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesaler
Wholesalers and medical agencies benefit from strong chronic disease demand, repeat monthly prescriptions, growing respiratory care market opportunities, reliable supply chain support, and attractive margins in the inhalation therapy segment.
Interested distributors, stockists, and wholesalers can contact Cafoli LifeCare Pvt Ltd to explore PCD pharma franchise opportunities, discuss pricing and business terms, obtain monopoly territory rights, and benefit from comprehensive marketing support, quality pharmaceutical products, and a dependable supply chain to grow their business successfully.